PTP1B has a prominent role in the metabolism, through the regulation of insulin signaling, leading to the development of PTP1B inhibitors for the treatment of type 2 diabetes or obesity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.